Calier Dynacan Dog 10-20Kg 3Pip

Each 1.34 ml pipette contains:
Active substances:
Fipronil ........................................................................................................................................................ 134.00 mg
(S)-methoprene ............................................................................................................................................... 120.60 mg
Excipients:
Butylated hydroxyanisole (E320) ................................................................................................................................0,27 mg
Butylated hydroxytoluene (E321) .............................................................................................................................0,13 mg
For the full list of excipients, see section 6.1.

Dorsal spot-on solution.
Clear colourless to slightly yellow solution.

Target species
Dogs weighing 10 to 20 kg.

For the treatment and prevention of flea infestations, alone or in association with ticks and/or biting lice.
- Elimination of fleas (Ctenocephalides spp.). Insecticidal efficacy against new infestations by adult fleas persists for 8 weeks.
fleas persists for 8 weeks. Prevention of flea multiplication by inhibition of egg development (ovicidal activity).
development of eggs (ovicidal activity) and larvae and pupae (larvicidal activity) originating from eggs laid by adult fleas for eight weeks.
laid by adult fleas for eight weeks after application.
- Elimination of ticks (Ixodes ricinus, Dermacentor reticulatus, Rhipicephalus sanguineus). The
veterinary medicinal product has an acaricidal efficacy that persists for up to 4 weeks against ticks.
- Elimination of biting lice (Trichodectes canis).
The veterinary medicinal product can be used as part of the treatment strategy for the control of Flea Allergic Dermatitis (FAD).
Allergic Flea Dermatitis (FAD).

In the absence of available data, this veterinary medicinal product should not be used in other animal species.
In the absence of available data, the veterinary medicinal product should not be used in puppies less than 8 weeks of age
of age and/or weighing less than 2 kg.
Do not use in sick (e.g. systemic diseases, fever) or convalescent animals.
Do not use in rabbits, as adverse drug reactions, including death, may occur.
This veterinary medicinal product is specially developed for dogs. Do not use in cats or ferrets as this may lead to overdosage.
this could lead to overdosage.

When applied as part of the treatment strategy for the control of flea bite allergic dermatitis, applications are recommended.
flea allergy dermatitis, monthly applications are recommended on the allergic animal and on other dogs and cats living in the same household.
same household.

Special precautions for use
Special precautions for use on animals
Weigh animals prior to application.
It is important to ensure that the veterinary medicinal product is applied in an area where the animal cannot lick it off and to ensure that animals do not lick it off.
ensure that animals do not lick each other after treatment.
Bathing or immersion in water should be avoided for 2 days after application of the veterinary medicinal product,
bathing more frequently than once a week should be avoided, as no studies have been conducted to investigate how this affects the efficacy of the veterinary medicinal product.
this affects the efficacy of the veterinary medicinal product. Emollient shampoos may be used prior to treatment,
but reduce the duration of flea protection to approximately 5 weeks when used weekly after application of the veterinary medicinal product.
weekly after application of the veterinary medicinal product. A weekly bathing with a medicated 2% chlorhexidine
2% chlorhexidine medicated shampoo did not affect flea efficacy during a 6-week study.
Adherence of individual ticks may occur. For this reason, it is not possible to completely exclude the
transmission of infectious diseases cannot be completely excluded if conditions are unfavourable.
For optimal control of flea and lice infestation in a multi-animal household, all cats and dogs should be
dogs should be treated simultaneously with an appropriate veterinary drug.
Pet fleas often infest the basket, bedding and regular resting areas of animals,
such as carpets and soft furnishings which should be treated, in case of massive infestation and at the start of control measures, with an insecticide.
control measures, with a suitable insecticide and regular vacuuming.
Do not apply the veterinary medicinal product to wounds or injured skin.
Avoid contact with the animal's eyes. In case of accidental contact with eyes, rinse immediately with plenty of water.
plenty of water.
Specific precautions to be taken by the person administering the veterinary medicinal product to animals
This veterinary medicinal product may cause irritation of the eyes, skin and mucous membrane. Therefore, contact with the veterinary medicinal product should be avoided.
contact of the veterinary medicinal product with the mouth, skin and eyes should be avoided.
Animals or humans with known hypersensitivity to insecticides or alcohol should avoid contact with this veterinary medicinal product.
contact with this veterinary medicinal product. Avoid contact of the contents with the fingers. If this occurs, wash hands with soap and water.
hands with soap and water.
After accidental eye exposure, rinse the eye thoroughly with clean water. If eye irritation persists
If eye irritation persists, seek medical attention immediately and show the package leaflet or label to the physician.
Wash hands with soap and water after application of the veterinary medicinal product.
Treated animals should not be touched until the application site is dry, and children should not be allowed to play with treated animals until the application site is dry.
children should not be allowed to play with treated animals until the application site is dry. It is therefore recommended not to treat
animals during the day, but should be treated in the evening, and that these newly treated animals should not sleep with the owners, especially with children.
with owners, especially children.
Do not smoke, drink or eat during application.

Animals or humans with known hypersensitivity to fipronil or to the excipients (see section 6.1) should avoid contact with the veterinary medicinal product.
avoid contact with the veterinary medicinal product.
Other precautions
Dogs should not be allowed to swim in streams or ponds for 2 days after application (see section 6.6).
section 6.6).

Very rare adverse reactions that have been reported after use include: transient skin reactions at the site of application, and
transient skin reactions at the site of application (skin discolouration, local hair loss, itching, redness), as well as
general itching or hair loss. After use, in very rare cases, excessive salivation, reversible nervous signs (increased sensitivity to the skin, increased sensitivity to the sun) have been observed.
(increased sensitivity to stimulation, depression, other nervous signs), vomiting or respiratory symptoms.
respiratory symptoms.
In case of licking, a brief period of excessive salivation may be observed in very rare cases, mainly due to the nature of the excipient.
mainly due to the nature of the excipient.
The frequency of adverse reactions should be classified according to the following groups:
- Very frequently (more than 1 animal per 10 animals treated exhibits adverse reactions).
- Frequently (more than 1 but less than 10 animals per 100 animals treated)
- Infrequently (more than 1 but less than 10 animals per 1,000 animals treated)
- Rarely (more than 1 but less than 10 animals per 10,000 animals treated)
- Very rarely (less than 1 animal per 10,000 animals treated, including isolated cases).

Use during pregnancy, lactation or laying
The veterinary medicinal product may be used during pregnancy and lactation.
4.8 Interaction with other medicinal products and other forms of interaction
None known.

Posology and route of administration
Solution for spot-on dorsal anointing.
Dosage:
- One 1.34 ml pipette per dog weighing over 10 kg and up to 20 kg.
This corresponds to a recommended minimum dose of 6.7 mg/kg fipronil and 6 mg/kg (S)-methoprene.
A monthly application is recommended when there is a high risk of re-infestation, if the dog is allergic to flea bites, or in the case of a high risk of re-infestation, or if the dog is allergic to flea bites.
flea bites, or in situations where tick control is required.
In the absence of safety studies, the minimum treatment interval is 4 weeks.
Method of administration:
Hold the pipette in an upright position. Tap the narrow end of the pipette to ensure that the contents remain inside the main body of the pipette.
remains inside the main body of the pipette. Detach the tip. Separate the animal's coat at the base of the neck in front of the shoulder blades.
Separate the animal's coat at the base of the neck in front of the shoulder blades until the skin is visible. Place the tip of the pipette on the skin and squeeze the pipette several times to empty the pipette.
pipette several times until its contents are completely emptied directly onto the skin in a single spot.
When applying the veterinary medicinal product to the skin, avoid excessive wetting of the coat, as the treated area may become damp or greasy after application.
may become damp or greasy after application. If this effect occurs, it will disappear within 24 hours after application.
24 hours after application.

Overdosage (symptoms, emergency measures, antidotes), if necessary
No adverse reactions have been observed in safety studies in the target species, in puppies
8 weeks old, growing dogs weighing approximately 2 kg treated once at five times the recommended dose.
recommended dose. The risk of experiencing adverse reactions (see section 4.6) may still be increased when overdosed, so
when overdosed, so animals should always be treated with a pipette size appropriate to their body weight.
body weight.
Itching may occur after application.

Waiting time(s)
Not applicable .

PHARMACOLOGICAL PROPERTIES
The veterinary medicinal product is an insecticidal and acaricidal solution for topical use, containing an association of
an adulticidal active ingredient, fipronil, in combination with an ovicidal and larvicidal active ingredient, (S)-methoprene.
methoprene.
Pharmacotherapeutic group: topical ectoparasiticides QP53